Panadol Osteo referral: a first for the Minister

Sussan Ley at desk (6Th community pharmacy agreement talks)
It is the first time Health Minister Sussan Ley has referred a company to the ACCC due to the “unique” circumstances surrounding the price rise for Panadol Osteo, a spokesman for the Minister told the AJP. The spokesperson says the Minister is also concerned about GSK’s market dominance and “misleading claims” and “justification” for the price

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Heart Foundation gives the Tick the flick
Next Panadol Osteo, admit it was a mistake: Guild